Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report

Euglycemic diabetic ketoacidosis (euDKA) related to sodium-glucose cotransporter 2 inhibitor (SGLT2-I), despite being reported as consistent, though infrequent, adverse effect in all trials on SGLT2-I in type 2 diabetes mellitus (T2D), still remains poorly known in the real world. On the other hand,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nappi, Felice, La Verde, Antonietta, Carfora, Giovanni, Garofalo, Carlo, Provenzano, Michele, Sasso, Ferdinando Carlo, De Nicola, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723212/
https://www.ncbi.nlm.nih.gov/pubmed/31405158
http://dx.doi.org/10.3390/medicina55080462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723212/
https://www.ncbi.nlm.nih.gov/pubmed/31405158
http://dx.doi.org/10.3390/medicina55080462

Ejemplares similares